Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
KZIA - Kazia Therapeutics Limited ADR - Stock Price Chart
TickerKZIA [NASD]
CompanyKazia Therapeutics Limited ADR
CountryAustralia
IndustryBiotechnology
Market Cap9.24MEPS (ttm)-29.44
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y11.47%
P/S6.08EPS next 5Y-
P/B-EPS Q/Q32.30%
Dividend-Sales Q/Q-
Insider Own-Inst Own11.53%
Insider Trans-Inst Trans12.52%
Short Float-Earnings-
Analyst Recom1.00Target Price15.00
Avg Volume895.52K52W Range2.86 - 79.00
Today 02:47PM Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps (Benzinga) +39.63%
08:00AM Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial (PR Newswire)
Jun-11-25 08:00AM Kazia Therapeutics Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunotherapy Resistance in Triple-Negative Breast Cancer (TNBC) (PR Newswire) +81.53%
Jun-05-25 08:00AM Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer (PR Newswire)
May-15-25 08:00AM Kazia Therapeutics Highlights Recent Progress and Provides Business Update (PR Newswire) -6.51%
Mar-31-25 07:30AM Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil (PR Newswire) -11.04%
Feb-20-25 08:46AM Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease (PR Newswire)
Jan-31-25 07:29AM Is Kazia Therapeutics (KZIA) One of the Best ASX Stocks to Buy According to Hedge Funds? (Insider Monkey) -16.84%
Jan-30-25 07:30AM Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer (PR Newswire) +37.68%
Jan-27-25 08:00AM Why Kazia Therapeutics (KZIA) Is Among the Best Australian Stocks to Buy Now? (Insider Monkey) -8.82%
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
RYTM - Rhythm Pharmaceuticals Inc - Stock Price Chart
TickerRYTM [NASD, RUT]
CompanyRhythm Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.66BEPS (ttm)-2.82
P/E-EPS this Y36.51%
Forward P/E-EPS next Y45.17%
PEG-EPS past 5Y-2.34%
P/S41.37EPS next 5Y-
P/B298.26EPS Q/Q65.72%
Dividend-Sales Q/Q25.94%
Insider Own8.53%Inst Own95.47%
Insider Trans-5.44%Inst Trans0.05%
Short Float8.18%EarningsMay 07/b
Analyst Recom1.00Target Price88.46
Avg Volume667.39K52W Range40.61 - 69.89
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHRISTOPHER PAUL GERMANOfficerJul 09 '25Proposed Sale65.143,817248,639Jul 09 04:17 PM
PAMELA CRAMEROfficerJul 09 '25Proposed Sale65.1415,5721,014,360Jul 09 04:17 PM
HUNTER SMITHOfficerJul 09 '25Proposed Sale65.1442,1202,743,697Jul 09 04:16 PM
JOSEPH J SHULMANOfficerJul 09 '25Proposed Sale65.147,969519,101Jul 09 04:16 PM
Smith Hunter CChief Financial OfficerJul 07 '25Option Exercise6.886,98648,064116,915Jul 08 04:30 PM
TLIH - Ten-League International Holdings Ltd - Stock Price Chart
TickerTLIH [NASD]
CompanyTen-League International Holdings Ltd
CountrySingapore
IndustryFarm & Heavy Construction Machinery
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.16M52W Range2.84 - 4.09
Ten-League International is a Singapore-based provider of turnkey project solutions. Our business primarily consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. We currently conduct our operations through our wholly-owned subsidiaries, Ten-League Engineering & Technology Pte. Ltd. and Ten-League Port Engineering Solutions Pte. Ltd., which were previously held by Ten-League Corp prior to our group reorganization for the listing of our ordinary shares. Together with the operating history of Ten-League Corp, we have a total of over 24 years of history operating our business.
ARTL - Artelo Biosciences Inc - Stock Price Chart
TickerARTL [NASD]
CompanyArtelo Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap14.77MEPS (ttm)-17.96
P/E-EPS this Y-218.03%
Forward P/E-EPS next Y82.68%
PEG-EPS past 5Y27.29%
P/S-EPS next 5Y28.82%
P/B18.12EPS Q/Q6.92%
Dividend-Sales Q/Q-
Insider Own0.83%Inst Own2.11%
Insider Trans0.00%Inst Trans-
Short Float4.72%EarningsMay 13/b
Analyst Recom1.00Target Price20.00
Avg Volume661.67K52W Range4.92 - 25.58
Jul-08-25Upgrade D. Boral Capital Hold → Buy $20
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
ANPA - Rich Sparkle Holdings Ltd - Stock Price Chart
TickerANPA [NASD]
CompanyRich Sparkle Holdings Ltd
CountryHong Kong
IndustrySpecialty Business Services
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.05M52W Range3.20 - 3.81
Rich Sparkle Holdings is a financial printing and corporate services provider specializing in designing and printing high quality financial materials in Hong Kong. Our service portfolio covers a myriad of deliverables, including listing documents, financial reports, fund documents, circulars and announcements. We offer our customers a wide range of convenient and quality financial printing services, from typesetting, proofreading, translation, design and printing. In addition, we also offer advisory services such as conducting internal control assessment and environmental, social and governance performance evaluation as well as other services including provision of co-working space, which could cater for our customersa different requirements. Our customers include a diverse range of domestic and international companies listed on the Stock Exchange of Hong Kong as well as companies that are preparing for their initial listing on the HK Stock Exchange.
XTLB - X.T.L. Biopharmaceuticals Ltd. ADR - Stock Price Chart
TickerXTLB [NASD]
CompanyX.T.L. Biopharmaceuticals Ltd. ADR
CountryIsrael
IndustryBiotechnology
Market Cap14.10MEPS (ttm)-0.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y10.20%
P/S31.32EPS next 5Y-
P/B2.59EPS Q/Q44.23%
Dividend-Sales Q/Q-
Insider Own2.46%Inst Own2.82%
Insider Trans0.00%Inst Trans1.98%
Short Float0.45%Earnings-
Analyst Recom1.00Target Price6.00
Avg Volume34.05K52W Range0.86 - 3.05
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
MYNZ - Mainz Biomed N.V - Stock Price Chart
TickerMYNZ [NASD]
CompanyMainz Biomed N.V
CountryGermany
IndustryDiagnostics & Research
Market Cap7.06MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-52.02%
P/S-EPS next 5Y-
P/B-EPS Q/Q-1121.45%
Dividend-Sales Q/Q-
Insider Own3.35%Inst Own6.13%
Insider Trans0.00%Inst Trans0.11%
Short Float0.21%EarningsApr 01/b
Analyst Recom1.00Target Price14.00
Avg Volume170.12K52W Range1.34 - 22.14
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
SOGP - Sound Group Inc ADR - Stock Price Chart
TickerSOGP [NASD]
CompanySound Group Inc ADR
CountrySingapore
IndustryInternet Content & Information
Market Cap23.62MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y43.92%
P/S-EPS next 5Y-
P/B-EPS Q/Q-505.60%
Dividend-Sales Q/Q-29.16%
Insider Own1.89%Inst Own4.57%
Insider Trans0.00%Inst Trans188.65%
Short Float7.01%Earnings-
Analyst Recom1.00Target Price13.75
Avg Volume670.58K52W Range1.18 - 6.20
Sound Group, Inc. is global audio-centric social and entertainment company, which engages in the provision of an audio platform. It focuses on audio entertainment and social networking. The company was founded by Jinnan Lai and Ning Ding in November 2010 and is headquartered in Singapore.
NVFY - Nova Lifestyle Inc - Stock Price Chart
TickerNVFY [NASD]
CompanyNova Lifestyle Inc
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap27.70MEPS (ttm)-1.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.92%
P/S2.78EPS next 5Y-
P/B4.09EPS Q/Q94.71%
Dividend-Sales Q/Q10.91%
Insider Own30.00%Inst Own1.15%
Insider Trans0.00%Inst Trans17.85%
Short Float1.46%Earnings-
Analyst Recom-Target Price-
Avg Volume66.17K52W Range0.38 - 2.08
Nova Lifestyle, Inc. engages in design, marketing, and manufacture of modern home furniture. The firm offers living room, urban dining, bedroom, and nova qwik products. It sells its products under the brand name Nova and Diamond Sofa. The company was founded by Ya Ming Wong and Yuen Ching Ho in 1992 and is headquartered in Commerce, CA.
GROV - Grove Collaborative Holdings Inc - Stock Price Chart
TickerGROV [NYSE]
CompanyGrove Collaborative Holdings Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap59.58MEPS (ttm)-0.77
P/E-EPS this Y118.67%
Forward P/E6.20EPS next Y68.23%
PEG-EPS past 5Y-
P/S0.31EPS next 5Y-
P/B-EPS Q/Q-5.12%
Dividend-Sales Q/Q-18.67%
Insider Own49.00%Inst Own14.90%
Insider Trans0.82%Inst Trans-27.45%
Short Float7.84%EarningsMay 14/a
Analyst Recom2.00Target Price2.10
Avg Volume131.85K52W Range1.02 - 1.95
Grove Collaborative Holdings, Inc. engages in the business of innovating sustainability-oriented consumer products. It is also involved in transforming consumer products into a positive force for human and environmental good. The company was founded by Stuart Landesberg and Christopher Clark in 2012 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glazer David A.DirectorJun 13 '25Buy1.157,2058,275156,118Jun 16 08:27 PM
Yurcisin Jeffrey MichaelPresident & CEOJun 13 '25Buy1.154,3444,982371,920Jun 16 05:25 PM
Yurcisin Jeffrey MichaelPresident & CEOJun 12 '25Buy1.121,5691,757367,576Jun 13 07:09 PM
Yurcisin Jeffrey MichaelPresident & CEOJun 10 '25Buy1.284,0315,156366,007Jun 11 02:12 PM
Yurcisin Jeffrey MichaelPresident & CEOJun 09 '25Buy1.318,90011,648361,976Jun 10 04:21 PM
12345671020